Updated 2026-09-01 · NCT07654374See eligibility →
Sponsor
Clinical trials sponsored by Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Active studies whose public registry record names Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics as lead sponsor.
4active studies
2recruiting now
1countries represented
74largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Updated 2026-08-10 · NCT07654361See eligibility →
Active, not recruitingPhase 2
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus
Updated 2026-04-27 · NCT07400588See eligibility →
Active, not recruitingPhase 2
Aleniglipron Phase 2 Body Composition Study
Updated 2026-03-03 · NCT07169942See eligibility →
Related sponsors
Novo Nordisk A/S71Eli Lilly and Company67University of Colorado, Denver36Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.